| 000 | 01679 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515032153.0 | ||
| 264 | 0 | _c20060822 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a0041-1345 | ||
| 024 | 7 |
_a10.1016/j.transproceed.2006.02.116 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeilman, R L | |
| 245 | 0 | 0 |
_aAcute rejection risk in kidney transplant recipients on steroid-avoidance immunosuppression receiving induction with either antithymocyte globulin or basiliximab. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cJun 2006 |
||
| 300 |
_a1307-13 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdrenal Cortex Hormones |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 |
_aAntilymphocyte Serum _xadverse effects |
| 650 | 0 | 4 | _aBasiliximab |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft Rejection _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xadverse effects |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aReddy, K S | |
| 700 | 1 | _aMazur, M J | |
| 700 | 1 | _aMoss, A A | |
| 700 | 1 | _aPost, D J | |
| 700 | 1 | _aPetrides, S | |
| 700 | 1 | _aMulligan, D C | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 38 _gno. 5 _gp. 1307-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2006.02.116 _zAvailable from publisher's website |
| 999 |
_c16390658 _d16390658 |
||